Eir Diagnostics ApS

CVR40339396

Key figures

Updated 13 Jul 2026
Return on assets
-12,952%
Return on equity
–
Current ratio
3.1%
Equity ratio
-3,103.1%

Profit and loss

Reporting period
Gross profit
370,098
Operating profit
-17,553,842
Finance income
12,832
Finance expenses
364,788
Tax expense
-1,260,261
Profit/loss for the year
-16,645,537

Employees

Reporting period
Avg. employees
0
Personnel costs
370 DKK

Balance sheet

Reporting period
Cash and cash equivalents
67,523
Current assets
135,530
Non-current assets
0
Total assets
135,530
Equity
-4,205,596
Liabilities
4,341,126
Current liabilities
4,341,126

Working capital

Reporting period
Other current receivables
32,503
Trade payables
260,066

Capital and dividend

Reporting period
Contributed capital
108,461
Retained earnings
-4,314,057

Investments and assets

Reporting period
Long-term investments and receivables
0
Property, plant and equipment
0

Annual report highlights

Official annual report · 2025

Business and development

Primary activities

Selskabets aktivitet består i at udvikle og kommecialisere patenter.

Development in activities and financial affairs

Der har ikke været væsentlige ændringer i aktiviteter og økonomiske forhold.

Going concernSelskabet har i 2025 indstillet al drifts- og udviklingsaktivitet.…

Risks and material matters

Going-concern uncertainty

1.

Going concernSelskabet har i 2025 indstillet al drifts- og udviklingsaktivitet.…

Significant events after the reporting period

Begivenheder efter regnskabsårets udløbDer er fra balancedagen og frem til i dag ikke indtrådt forhold, som forrykker vurderingen af årsrapporten.

Commitments and security

Contingent liabilities

8.Kontraktlige forpligtelser og eventualposter m.v.

Ingen

Mortgages and collateral

Der er ingen pantsætninger eller sikkerhedsstillelser.

Create a free account to see up to 9 years of financial history

Create free account